BookYee Guan Yap, A John Camm.
Summary: Atrial fibrillation (AF) affects an estimated 1?2% of the population and is the most common cause of sustained cardiac arrhythmia. Critically, the number of patients developing AF is expected to double in the next five decades, leading to increased incidence of stroke, heart failure and other serious thromboembolic events. Essentials of Atrial Fibrillation is a timely investigation of current pharmaceutical trends, clinical guidelines, novel treatments, and ongoing pipeline developments, including ground-breaking advances in the use of novel oral anticoagulants.
Contents:
Epidemiology of atrial fibrillation
Pathogenesis of atrial fibrillation
Classification, diagnosis, and assessment of atrial fibrillation
Rate and rhythm control strategies for atrial fibrillation
Anticoagulant treatment strategies for atrial fibrillation.